Systems and methods for treatment of hearing using dihexa
US-2024424050-A1 · Dec 26, 2024 · US
US9351490B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9351490-B2 |
| Application number | US-201414178061-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 11, 2014 |
| Priority date | Sep 6, 2006 |
| Publication date | May 31, 2016 |
| Grant date | May 31, 2016 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to targeting peptides capable of specifically binding to microbial organisms (e.g., P. aeruginosa or S. mutans ), antimicrobial peptides having antimicrobial activities, and specifically/selectively targeted antimicrobial peptides (STAMPs). In addition, the present invention provides methods of selectively killing or inhibiting microbial organisms by using the peptides or compositions provided by the present invention.
Opening claim text (preview).
What is claimed is: 1. A method of selectively killing a Streptococcus mutans , said method comprising contacting said S. mutans with an amount of a construct effective to kill an S. mutans , wherein said construct comprises a targeting peptide that binds Streptococcus mutans , the amino acid sequence of said peptide consisting of the sequence TFFRLFNRSFTQALGK (SEQ ID NO:2) attached to a an antimicrobial peptide. 2. The method of claim 1 , wherein the amino acid sequence of said antimicrobial peptide comprises a novispirin amino acid sequence or a fragment thereof having antimicrobial activity. 3. The method of claim 1 , wherein the amino acid sequence of said antimicrobial peptide comprises the sequence KNLRIIRKGIHIIKKY (SEQ ID NO:3). 4. The method of claim 1 , wherein the amino acid sequence of said antimicrobial peptide consists of the sequence KNLRIIRKGIHIIKKY (SEQ ID NO:3). 5. The method according to claim 1 - 3 , or 4 , wherein the targeting peptide is attached to the antimicrobial peptide by a linker peptide. 6. The method of claim 5 , wherein the targeting peptide is attached to the antimicrobial peptide by a linker peptide, where the amino acid sequence of said linker peptide is selected from the group consisting of GGG (SEQ ID NO:17), AAA (SEQ ID NO:18), SAT (SEQ ID NO:19), ASA (SEQ ID NO:20), SGG (SEQ ID NO: 21), PYP (SEQ ID NO:22), SGS (SEQ ID NO:23), GGS (SEQ ID NO:24), SPS(SEQ ID NO:25), PSGSP (SEQ ID NO:26), PSPSP (SEQ ID NO:27), and GGSGGS (SEQ ID NO:28). 7. The method of claim 1 , wherein the carboxyl terminus of said antimicrobial peptide is amidated. 8. The method of claim 1 , wherein the targeting peptide attached to the antimicrobial peptide consists of the amino acid sequence TFFRLFNRSFTQALGKGGGKNLRIIRKGIHIIKKY (SEQ ID NO:4). 9. The method of claim 8 , wherein the carboxyl terminus of said peptide is amidated. 10. The method of claim 8 , wherein said S. mutans is on an oral soft tissue or on teeth. 11. The method of claim 8 , wherein said S. mutans is present in a biofilm. 12. The method of claim 1 , wherein said S. mutans is on an oral soft tissue or on teeth. 13. The method of claim 1 , wherein said S. mutans is present in a biofilm.
Antibacterial agents · CPC title
having 12 to 20 amino acids (gastrins C07K14/595; somatostatins C07K14/655; melanotropins C07K14/68) · CPC title
Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers · CPC title
Peptides having 12 to 20 amino acids {(A61K38/043 - A61K38/046 take precedence)} · CPC title
containing a localisation/targetting motif · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.